Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms C 02, C02 |
Target |
Mechanism HK2 inhibitors(Hexokinase type II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H28Cl2N6O5 |
InChIKeyOFEUWOIETWIJID-UHFFFAOYSA-N |
CAS Registry3033812-84-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | CN | 27 Jun 2023 |